| ||||||||||||||
|
|
|||||||||||||


From the Writing Committee Members; *Society for Vascular Medicine and Biology Official Representative;
American Society of Nuclear Cardiology Official Representative;
Heart Rhythm Society Official Representative;
Society for Vascular Surgery Official Representative; ||American Society of Echocardiography Official Representative; ¶Society of Cardiovascular Anesthesiologists Official Representative; #Society for Cardiovascular Angiography and Interventions Official Representative.
The American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Practice Guidelines makes every effort to avoid any actual, potential, or perceived conflict of interest that might arise as a result of an industry relationship or personal interest of the writing committee. Specifically, all members of the writing committee, as well as peer reviewers of the document, were asked to provide disclosure statements of all such relationships that might be perceived as real or potential conflicts of interest. These statements are reviewed by the parent task force, reported orally to all members of the writing committee at each meeting, and updated and reviewed by the writing committee as changes occur. Please see Appendix 1 for author relationships with industry and Appendix 2 for peer reviewer relationships with industry.
These guidelines attempt to define practices that meet the needs of most patients in most circumstances. These guideline recommendations reflect a consensus of expert opinion after a thorough review of the available, current scientific evidence and are intended to improve patient care. If these guidelines are used as the basis for regulatory/payer decisions, the ultimate goal is quality of care and serving the patients best interests. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and patient in light of all the circumstances presented by that patient.
Sidney C. Smith, Jr., MD, FACC, FAHA
Chair, ACC/AHA Task Force on Practice Guidelines
Elliot M. Antman, MD, FACC, FAHA
Immediate Past-Chair, ACC/AHA Task Force on Practice Guidelines
This article has been cited by other articles:
![]() |
T. Kurita, K. Takata, K. Morita, and S. Sato Lipophilic {beta}-adrenoceptor antagonist propranolol increases the hypnotic and anti-nociceptive effects of isoflurane in a swine model Br. J. Anaesth., June 1, 2008; 100(6): 841 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Nemergut, K. E. Littlewood, and D. G. de Souza Preoperative Hematocrit Levels and Outcomes After Noncardiac Surgery JAMA, October 3, 2007; 298(13): 1512 - 1513. [Full Text] [PDF] |
||||
![]() |
L. A. Fleisher Perioperative {beta}-Blockade: How Best to Translate Evidence into Practice Anesth. Analg., January 1, 2007; 104(1): 1 - 3. [Full Text] [PDF] |
||||
|